{
    "Trade/Device Name(s)": [
        "Xpert\u00ae MRSA/SA Blood Culture Assay"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K130894",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101879",
        "K071026"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQX"
    ],
    "Summary Letter Date": "March 29, 2013",
    "Summary Letter Received Date": "April 2, 2013",
    "Submission Date": "March 29, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Staphylococcus aureus DNA",
        "Methicillin-resistant Staphylococcus aureus DNA"
    ],
    "Specimen Type(s)": [
        "Positive blood culture"
    ],
    "Specimen Container(s)": [
        "BD BACTECTM Plus Aerobic/F",
        "BacT/ALERT\u00ae SA (Standard Aerobic)",
        "VersaTREK REDOX I (Aerobic) blood culture bottles"
    ],
    "Instrument(s)/Platform(s)": [
        "GeneXpert Dx Systems",
        "GeneXpert Infinity Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Automated real-time polymerase chain reaction (PCR)",
        "Nucleic acid amplification test",
        "Fluorogenic hybridization probe detection"
    ],
    "Methodologies": [
        "Real-time PCR",
        "Nucleic acid amplification",
        "Automated sample preparation and detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Cartridge",
        "Reagent",
        "Instrument",
        "Platform"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert MRSA/SA Blood Culture Assay, a real-time PCR-based automated qualitative test for rapid detection of MRSA and SA DNA in positive blood cultures",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test intended for detection of Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) DNA directly from positive blood culture samples as an aid in detection, to be used in conjunction with other laboratory tests and clinical data; not intended for monitoring treatment.",
    "fda_folder": "Microbiology"
}